EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas

European Journal of Cancer

Volumn 47, Issue 15, 2011, Pages 2364-2372

  Nakata, Yoshimi ^a   Uzawa, Narikazu ^a   Takahashi, Ken Ichiro ^a   Sumino, Jun ^a   Michikawa, Chieko ^a   Sato, Hiroaki ^a   Sonoda, Itaru ^a   Ohyama, Yoshio ^a   Okada, Norihiko ^a   Amagasa, Teruo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Epidermal growth factor receptor (EGFR); Fluorescence in situ hybridisation (FISH); Immunohistochemistry (IHC); Oral tongue; Squamous cell carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MUTATION; ORAL TONGUE SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RELIABILITY; SURVIVAL RATE;

BIOPSY; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TONGUE NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 80053347280     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.07.006     Document Type: Article

References (38)

1. F. Ciardiello, and G. Tortora Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs Eur J Cancer 39 2003 1348 1354 (Pubitemid 36773776)
2. J.R. Grandis, and D.J. Tweardy Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer Cancer Res 53 2003 3579 3584
3. K.K. Ang, B.A. Berkey, and X. Tu Impact of epidermal growth factor receptor expression in survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 2002 7350 7356 (Pubitemid 36025259)
4. E.E. Cohen, F. Rosen, and W.M. Stadler Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck J Clin Oncol 21 2003 1980 1987 (Pubitemid 46606387)
5. J. Baselga, J.M. Trigo, and J. Bourhis Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck J Clin Oncol 23 2005 5568 5577
6. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578 (Pubitemid 43209104)
7. F.R. Hirsch, M. Varella-Garcia, and J. McCoy Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: A southwest Oncology Group study J Clin Oncol 23 2005 6838 6845
8. F. Cappuzzo, F.R. Hirsch, and E. Rossi Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer J Natl Cancer Inst 97 2005 643 655 (Pubitemid 40812628)
9. G. Selvaggi, S. Novello, and V. Torri Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer Ann Oncol 15 2004 28 32 (Pubitemid 38139599)
10. J.R. Grandis, M.F. Melhem, and W.E. Gooding Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival J Natl Cancer Inst 90 1998 824 832 (Pubitemid 28280548)
11. J.J. Sheu, C.H. Hua, and L. Wan Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma Cancer Res 69 2009 2568 2576
12. M.A. Sheikh Ali, M. Gunduz, and H. Nagatsuka Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma Cancer Sci 99 2008 1589 1594
13. R.R. Seethala, W.E. Gooding, and P.N. Handler Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes Clin Cancer Res 14 2008 1303 1309 (Pubitemid 351413908)
14. L.E. Morrison, K.K. Jacobson, and M. Friedman Aberrant EGFR and chromosome 7 associated with outcome in laryngeal cancer Laryngoscope 115 2005 1212 1218 (Pubitemid 40962358)
15. C.H. Chung, K. Ely, and L. McGavran Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas J Clin Oncol 24 2006 4170 4176 (Pubitemid 46622295)
16. S. Temam, H. Kawaguchi, and A.K. El-Nagger Epidermal growth factor receptor copy number alterations correlated with poor clinical outcome in patients with head and neck squamous cancer J Clin Oncol 25 2007 2164 2170 (Pubitemid 46954638)
17. M. Ryott, D. Wangsa, and K. Heselmeyer-Haddad EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma Eur J Cancer 45 2009 1700 1708
18. K. Takahashi, N. Uzawa, and K. Myo Simultaneous assessment of cyclin D1 and epidermal growth factor receptor gene copy number for prognostic factor in oral squamous cell carcinomas Oral Sci Int 6 2009 8 20
19. R.P. Takes, R.J. Baatenburg de Jong, and E. Schuuring Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell Anticancer Res 18 1998 4793 4800 (Pubitemid 29042062)
20. C. Fakhry, W.H. Westra, and S. Li Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 2008 261 269 (Pubitemid 351480538)
21. N. Reimers, H.U. Kasper, and S.J. Weissenborn Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer Int J Cancer 120 2007 1731 1738 (Pubitemid 46399359)
22. P.M. Weinberger, Z. Yu, and B.G. Haffty Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer Clin Cancer Res 10 2004 5684 5691 (Pubitemid 39180943)
23. L.H. Sobin, and C. Wittekind TNM classification of malignant tumors 5th Edn. 1997 John Wiley & Sons New York, NY
24. World Health Organization International histological classification of tumors 2nd ed. 1998 Springer-Verlag Berlin, Germany
25. P.A. Jacobsson, G.M. Eneroth, D. Killander, G. Moeberger, and B. Martenssen A histological classification and grading of malignancy in carcinoma of larynx Acta Radiol 12 1973 1 18
26. E. Yamamoto, G. Kohama, H. Sunakawa, M. Iwai, and H. Hiratsuka Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity Cancer 51 1983 2175 2180 (Pubitemid 13106840)
27. R. Miyamoto, N. Uzawa, and S. Nagaoka Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies Cancer 95 2000 2152 2159
28. K. Myo, N. Uzawa, and R. Miyamoto Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM stage I and II squamous cell carcinoma of the oral cavity Cancer 104 2005 2709 2716 (Pubitemid 41798281)
29. P. Sunpaweravong, S. Sunpaweravong, and P. Puttawibul Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma J Cancer Res Clin Oncol 131 2005 111 119 (Pubitemid 40192936)
30. N. Uzawa, I. Sonoda, and K. Myo Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas Cancer 110 2007 2230 2239 (Pubitemid 350100745)
31. E. Gobhart, J. Ries, J. Wiltfang, T. Liehr, and T. Efferth Genomic gain of the epidermal growth factor receptor harboring band 7p12 is part of a complex pattern of genomic imbalances in oral squamous cell carcinomas Arch Med Res 35 2004 385 394 (Pubitemid 40018178)
32. H. Sato, N. Uzawa, and K. Takahashi Prognostic utility of chromosomal instability detected by fluorescence in situ hybridization in fine-needle aspirates from oral squamous cell carcinomas BMC Cancer 10 2010 182
33. S. Dacic, M. Flanagan, and K. Cieply Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma Am J Clin Pathol 125 2006 860 865 (Pubitemid 43801536)
34. A. Ooi, T. Takehana, and X. Li Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study Mod Pathol 17 2004 895 904 (Pubitemid 38993773)
35. F.R. Hirsch, R.S. Herbst, and C. Olsen Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy J Clin Oncol 26 2008 3351 3357
36. M. Moroni, S. Veronese, and S. Benvenuti Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study Lancet Oncol 6 2005 279 286 (Pubitemid 40590264)
37. F. Cappuzzo, G. Finocchiaro, and E. Rossi EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients Ann Oncol 19 2008 717 723 (Pubitemid 351461042)
38. A. Sartore-Bianchi, M. Moroni, and S. Veronese Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab J Clin Oncol 25 2007 3238 3245 (Pubitemid 47325607)